What we do – Education

Annual Congress of ECCO

Every February/March, we organise the ECCO Congress representing a key date on the international IBD calendar. We have organised 19 Congresses so far, attracting a very large number of attendees with expertise in Inflammatory Bowel Diseases from over 100 countries.


ECCO provides a balanced scientific programme including a range of symposia, as well as excellent training opportunities. Moreover the congress is an excellent networking opportunity for the best European gastroenterologists and IBD experts.

  • ECCO’24 Stockholm

    ECCO’24 Stockholm

    ECCO Congress participants (Source: ECCO Office)

  • Top 20 Countries at ECCO’24 Stockholm

    Top 20 Countries at ECCO’24 Stockholm

    Statistical overview – Top 20 countries at ECCO’22 Virtual (Source: ECCO Office)

    The industry exhibition is a key event for Corporate Members and industry partners, offering the opportunity to network face-to-face with purchasing decision makers in the field of IBD. The continuous increase in congress participation is evidence of the dynamic spirit of ECCO. Our membership has grown not only with gastroenterologists, but with other professions such as paediatric specialists, surgeons, radiologists, pathologists and scientists interested in IBD.


    Upcoming Congress of ECCO

    With its steadily increasing number of participants, the ECCO Congress has become the leading world congress for Inflammatory Bowel Diseases and we look forward to welcoming you to a highly diverse programme with a major focus on precision medicine for IBD. The 20th Congress of ECCO will take place in Berlin, February 19-22, 2025.

    The Scientific Programme themed "Sustainability in IBD and beyond" with content delivered by the best professionals in the field of IBD and gastroenterology we ensure high quality focus on care across the world from epidemiology to international panel case reviews, crossing disciplinary borders from paediatric to adult care and challenging cases, among others. In parallel, as part of our well established and recognised Educational Programme, 14 courses offer once again unique learning experience to the participants.

    For further details about the congress please visit the ECCO'25 homepage.


    ECCO Exhibitor & Sponsor Prospectus

    Since 2021 Sponsorship & Exhibitor bookings are possible via the new Industry Webshop ensuring user-friendly handling of bookings. As always, our Congress offers numerous advertising options to reach KOL’s, as well as the entire IBD Community.

    In the Industry Webshop of ECCO'25 you can book exhibition space, satellite symposia slots, venue branding and several other sponsorship items.


    Educational courses

    Below you may see a short description of our educational courses held at the Congress. For more information and more detailed programme, please visit the ECCO'25 website.


    ECCO Educational Workshops

    The primary goal of this educational activity is the implementation of the ECCO Guidelines on Crohn’s Disease and Ulcerative Colitis. The programme of these workshops is created around clinical cases, with the intention of being as educational and interactive as possible, to allow participants to take active part in the discussions. Every year, four to five ECCO Educational Workshops are organised within Europe and one to two are held outside of Europe.


    e-Learning

    To foster learning and align practices with the ECCO Guidelines, we have created the e-Learning platform, which is frequently updated to include all the latest developments and to keep all the learning materials up-to-date.

    The e-Learning platform comprises a searchable e-Library that contains multimedia reference material (Talking Heads, Educational Audio Podcasts, Skills Videos) in conjunction with interactive case-based e-Courses.

    More recently, we have also added the IBD Communication Toolbox, which is a series of podcasts, recorded by gastroentherologists, where you can hear how IBD experts deal with questions that are commonly asked by patients.